Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1
Li Xu(Zhejiang University), Qiaojun He(Zhejiang University-University of Edinburgh Institute)
Cited by 35
Related Papers
Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells
|Acta Pharmacologica Sinica|2019|98
Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells
|Oncotarget|2016|76
s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand–foot skin reaction that can be reversed by nicotinamide
|Cell Research|2020|44
MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia
|PLoS ONE|2013|40
STAT3 dictates β-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia
|Cell Death and Differentiation|2019|36